- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 174-188 of
1,170 results
No. 619
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 619 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 616
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 616 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 632
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 632 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 615
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 615 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 624
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 624 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 633
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 633 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 628
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 628 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 630
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 630 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
57 Opposition: Patent Owner’s Opposition to Petitioner’s Motion for Discovery
Document
IPR2023-00884, No. 57 Opposition - Patent Owner’s Opposition to Petitioner’s Motion for Discovery (P.T.A.B. May. 17, 2024)
|
|
Cite Document
56 Motion Other: Motion for Discovery Pursuant to 37 CFR § 4251b
Document
IPR2023-00884, No. 56 Motion Other - Motion for Discovery Pursuant to 37 CFR § 4251b (P.T.A.B. May. 10, 2024)
|
|
Cite Document
No. 174
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 174 (N.D.W.Va. Dec. 15, 2022)
|
|
Cite Document
No. 100
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 100 (N.D.W.Va. Feb. 14, 2024)
|
|
Cite Document
No. 94
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 94 (N.D.W.Va. Feb. 9, 2024)
|
|
Cite Document
No. 143
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 143 (N.D.W.Va. Dec. 6, 2022)
|
|
Cite Document
No. 82
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 82 (N.D.W.Va. Jan. 26, 2024)
|
|
Cite Document
